United States· US:69097-301_20c14bd6-1106-433b-83ab-c2167b873987

Efavirenz

A efavirenz product containing efavirenz, registered in United States by Cipla USA Inc.. The same ATC class is registered in 16 of our 19 countries.

ATC J05AG03US label

Checked against FDA National Drug Code directory (United States) on September 27, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about efavirenzAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Efavirenz is registered in 16 of 19 countries.

Countries holding a registration under ATC J05AG03 (efavirenz), each read from that country’s own register.

This record: United States, from FDA National Drug Code directory (United States)
9 of them publish a price we can compare per daily dose

Search efavirenz products by name

Efavirenz · ATC J05AG03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of efavirenz costs, country by country.

Normalised to the WHO defined daily dose (0.6 g), the median price runs from $9.90 in Switzerland to $66.82 in France — a ×6.7 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Efavirenz · price per daily dose (0.6 g)

USD · FX 28 Sept 2026

FR France$66.82
CH Switzerland$9.90

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FDA National Drug Code directory (United States)

Active substance: EFAVIRENZ
Manufacturer: Cipla USA Inc.
Country: United States (US)
ATC code: J05AG03
ATC class: Efavirenz
Defined daily dose: 0.6 g, O
Reimbursed: Not published by this register
Source register: FDA National Drug Code directory (United States)
Last checked: September 27, 2026

Packs & prices · 2

ndc11
69097-301-02
ndc11
6909730102
30 TABLET, FILM COATED in 1 BOTTLE (69097-301-02)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

486 interactions on record for efavirenz.

Graded by severity as the source publishes them — 137 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check efavirenz against other medicines How interaction checks work

Efavirenz · interactions on record

486 records

137 severe
278 moderate
8 minor
48 info

Most severe, free to view

CisaprideA03FA02severe
OndansetronA04AA01severe
GranisetronA04AA02severe
DolasetronA04AA04severe

15 more interactions with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Efavirenz in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All efavirenz products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

Austria · Efavirenz Sandoz
Belgium · Efavirenz Viatris
Cyprus · Efavirenz Aurobindo
Germany · Efavirenz Aurobindo
Denmark · Efavirenz "sandoz", Efavirenz Aurobindo
Estonia · Efavirenz Sandoz
Spain · Efavirenz Aurovitas
Finland · Efavirenz Aurobindo, Efavirenz Sandoz
France · Efavirenz Arrow, Efavirenz Sandoz
United Kingdom (Northern Ireland) · Efavirenz Accord, Efavirenz Amarox
Iceland · Efavirenz Teva
Liechtenstein · Efavirenz Teva
Netherlands · Efavirenz Accord, Efavirenz Aurobindo
Norway · Efavirenz Sandoz, Efavirenz Teva
Portugal · Efavirenz Aurobindo, Efavirenz Farmoz
Sweden · Efavirenz Aurobindo, Efavirenz Medical Valley

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ede5144e-963c-4ccf-81be-2787234399a9
GET /v1/drugs/ede5144e-963c-4ccf-81be-2787234399a9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "ORAL",
  "source": "ndc",
  "strength": "600",
  "substance": "EFAVIRENZ",
  "productndc": "69097-301",
  "dosage_form": "TABLET, FILM COATED",
  "dea_schedule": null,
  "strength_unit": "mg/1",
  "application_number": "ANDA204766",
  "marketing_category": "ANDA"
}

API reference MCP server Plans

See everything about efavirenz.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console